To investigate the co-expression of ERα and ERβ in breast tumor samples, we analyzed a breast cancer tissue microarray (TMA) using the quantitative immunofluorescence AQUA® technology (HistoRx) that allows the quantitative measurement of proteins of interest within subcellular location of tissue samples by calculation of an AQUA® score. This evidence concerns the gene ESR2 and breast carcinoma.